Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
-387K
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
-$11.5M
-
Put/Call ratio
-
0.3
-
Number of buys
-
108
-
Number of sells
-
-121
-
Price
-
$29.85
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q1 2025
270 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q1 2025.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.45M shares), Rubric Capital Management LP (3M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.64M shares), VANGUARD GROUP INC (2.25M shares), Invesco Ltd. (1.63M shares), RENAISSANCE TECHNOLOGIES LLC (1.62M shares), PRINCIPAL FINANCIAL GROUP INC (1.57M shares), STATE STREET CORP (1.38M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.37M shares), and DIMENSIONAL FUND ADVISORS LP (909K shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.